Premium
Up‐Regulation of Follistatin‐Like 1 By the Androgen Receptor and Melanoma Antigen‐A11 in Prostate Cancer
Author(s) -
Su Shifeng,
Parris Amanda B.,
Grossman Gail,
Mohler James L.,
Wang Zengjun,
Wilson Elizabeth M.
Publication year - 2017
Publication title -
the prostate
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.295
H-Index - 123
eISSN - 1097-0045
pISSN - 0270-4137
DOI - 10.1002/pros.23288
Subject(s) - prostate cancer , androgen receptor , chromatin immunoprecipitation , cancer research , gene knockdown , biology , androgen , coactivator , medicine , cancer , endocrinology , transcription factor , gene expression , cell culture , gene , promoter , hormone , biochemistry , genetics
BACKGROUND High affinity androgen binding to the androgen receptor (AR) activates genes required for male sex differentiation and promotes the development and progression of prostate cancer. Human AR transcriptional activity involves interactions with coregulatory proteins that include primate‐specific melanoma antigen‐A11 (MAGE‐A11), a coactivator that increases AR transcriptional activity during prostate cancer progression to castration‐resistant/recurrent prostate cancer (CRPC). METHODS Microarray analysis and quantitative RT‐PCR were performed to identify androgen‐regulated MAGE‐A11‐dependent genes in LAPC‐4 prostate cancer cells after lentivirus shRNA knockdown of MAGE‐A11. Chromatin immunoprecipitation was used to assess androgen‐dependent AR recruitment, and immunocytochemistry to localize an androgen‐dependent protein in prostate cancer cells and tissue and in the CWR22 human prostate cancer xenograft. RESULTS Microarray analysis of androgen‐treated LAPC‐4 prostate cancer cells indicated follistatin‐like 1 (FSTL1) is up‐regulated by MAGE‐A11. Androgen‐dependent up‐regulation of FSTL1 was inhibited in LAPC‐4 cells by lentivirus shRNA knockdown of AR or MAGE‐A11. Chromatin immunoprecipitation demonstrated AR recruitment to intron 10 of the FSTL1 gene that contains a classical consensus androgen response element. Increased levels of FSTL1 protein in LAPC‐4 cells correlated with higher levels of MAGE‐A11 relative to other prostate cancer cells. FSTL1 mRNA levels increased in CRPC and castration‐recurrent CWR22 xenografts in association with predominantly nuclear FSTL1. Increased nuclear localization of FSTL1 in prostate cancer was suggested by predominantly cytoplasmic FSTL1 in benign prostate epithelial cells and predominantly nuclear FSTL1 in epithelial cells in CRPC tissue and the castration‐recurrent CWR22 xenograft. AR expression studies showed nuclear colocalization of AR and endogenous FSTL1 in response to androgen. CONCLUSION AR and MAGE‐A11 cooperate in the up‐regulation of FSTL1 to promote growth and progression of CRPC. Prostate 77:505–516, 2017 . © 2016 Wiley Periodicals, Inc.